Thank you very much, operator, and good morning, everybody, and thank you for joining the Compass Third Quarter 2025 Earnings Call. Joining us today will be Robert Reffkin, our Founder and CEO; and ...

The company now has 17,752 principal agents. Founder and CEO Robert Reffkin said in a new earnings report that he believes his company will pull ahead in 2025. Turn up the volume on your real estate ...

Compass’ second quarter was punctuated with “all-time highs,” even as the housing market continues to plumb all-time lows. The residential brokerage reported record numbers in 10 metrics, including ...

View post: 2027 Infiniti QX65 vs. 2026 Genesis GV80 Coupe: I Drove Both Luxury SUVs—Here’s My Honest Comparison Review In recent times, the compact crossover segment has become one of the most popular ...

The all-new Jeep Compass is right around the corner. The Stellantis-owned brand just announced that its world premiere will take place in Europe this spring. The official unveiling date is still being ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Stellantis-owned Jeep has opened the order books for the 2025 model year Compass in the United States, where prices kick off at $25,900 for the Sport grade. Said retail price does not include freight, ...

Revenue in Q1 Grew 28.7% YoY and Organic Revenue Grew 14.6% YoY Quarterly Market Share Grew 125bps YoY to a Record 6.0%; Organic Share Was Up 82bpsOperating Cash Flow Grew 169% YoY to a Record $23.1 ...

View post: 2027 Audi Q7 vs 2027 BMW X5: The Cheaper One Has the Edge The Jeep Compass enters a third model year with the updates that made it a much better vehicle, namely, the turbocharged 2.0-liter ...

BOSTON, March 05, 2026 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to ...

Ladies and gentlemen, thank you for joining us and welcome to Compass, Inc.'s First Quarter 2025 Earnings Call. [Operator Instructions] I will now hand the conference over to Compass' Head of Investor ...